Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/30/1991 | EP0453658A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases |
10/30/1991 | EP0438519A4 Therapeutic peptides |
10/30/1991 | EP0179808B1 Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders |
10/30/1991 | CN1055735A Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |
10/29/1991 | WO1991017116A1 Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use |
10/29/1991 | US5061813 Substituted cyanoimino benzopyranes |
10/29/1991 | US5061722 Hypotensive agents; e.g. ramipril |
10/29/1991 | US5061718 Benzothiazolylmethoxy compounds, pharmaceutical compositions comprising the same and their use as anti-inflammatory or anti-allergenic agents |
10/29/1991 | US5061710 Mercapto-acylamino acid antihypertensives |
10/29/1991 | US5061703 Alzheimer*s disease |
10/29/1991 | US5061694 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
10/29/1991 | CA2081351A1 1-(2h-1-oxo-3, 4-dihydronaphtyl-6) -acetyl-piperidines, process for their preparation and therapeutic use |
10/29/1991 | CA1291483C Process for the preparation of encainide and an intermediate therefor |
10/29/1991 | CA1291478C Pyridazodiazepine derivatives |
10/28/1991 | WO1991017153A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use |
10/28/1991 | CA2081204A1 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use |
10/24/1991 | CA2040965A1 Pharmaceutical compositions comprising tnf for induction of nerve regeneration |
10/24/1991 | CA2040885A1 Substituted benzhydryl 2-hydroxypropyl piperazine derivatives |
10/23/1991 | EP0453365A1 Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination |
10/23/1991 | EP0453210A2 Pyridine derivatives |
10/23/1991 | EP0453197A1 Amine derivatives |
10/23/1991 | EP0452850A1 4-[3-(4-Oxothiazoldinyl)]butynylamines, a process for their preparation and their use as medicaments |
10/23/1991 | EP0452712A1 4-Quinolyl-dihydropyridines, process for their prepatation and their use in medicaments |
10/23/1991 | EP0452697A1 Stabilizer for 4-ethyl-2-hydroxyimino5-nitro-3-hexenamide-containing preparation and stabilizing method therefor |
10/23/1991 | EP0452587A1 Dihydroxy sulfonamide and sulfinamide renin inhibitors |
10/23/1991 | EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity |
10/23/1991 | EP0291507B1 Electronic inclinometer |
10/23/1991 | CN1055537A 3,5-disubstituted-2-isoxazolines, process for their preparation, agents containing them and their use |
10/23/1991 | CN1014409B Manufacturing process for asscorbic acid derivative |
10/22/1991 | US5059712 Isolating aminoarginine and use to block nitric oxide formation in body |
10/22/1991 | US5059624 Guanidine derivatives having hypotensive activity, composition containing them and process for obtaining them |
10/22/1991 | US5059601 Imidazolone derivatives with activity on central nervous system and antihypertensive activity, preparation methods thereof, and pharmaceutical compositions containing them |
10/22/1991 | CA1291165C Alkylsulfonamidophenylalkylamines |
10/22/1991 | CA1291164C Indane sulfonamide antiarrythmic agents |
10/22/1991 | CA1291138C Alkoxyimino ether derivatives of 5-acyl-2(1h)- pyridinones |
10/22/1991 | CA1291131C 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8,-inter- m-phenylene pgi _derivatives |
10/22/1991 | CA1291121C 12- and 13-bromoergoline derivatives |
10/21/1991 | WO1991016298A1 Antiinflammatory hydroxamic acids and n-hydroxyureas |
10/21/1991 | CA2078216A1 Antiinflammatory hydroxamic acids and n-hydroxyureas |
10/20/1991 | CA2040747A1 Pyridine derivatives |
10/20/1991 | CA2040107A1 Amine derivatives |
10/18/1991 | WO1991016306A1 An improved process for the preparation of substituted indolone derivatives |
10/17/1991 | WO1991016305A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
10/17/1991 | WO1991015479A1 Substituted pyrazoles, isoxazoles and isothiazoles |
10/17/1991 | WO1991015475A1 Novel vitamin d analogues |
10/17/1991 | WO1991015214A1 Medicament for treating hyperlipidaemia and/or atherosclerosis |
10/17/1991 | WO1991015202A1 Pharmaceutical aqueous solution of 4-[2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid |
10/17/1991 | WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
10/17/1991 | CA2080582A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
10/17/1991 | CA2079343A1 Substituted pyrazoles, isoxazoles and isothiazoles |
10/17/1991 | CA2063588A1 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis |
10/16/1991 | EP0452204A1 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them |
10/16/1991 | EP0452107A1 Pyrimidinedione derivatives and antiarrythmic agents containing same |
10/16/1991 | EP0452074A2 Ergoline-8-carboxamides for blocking 5HT receptors |
10/16/1991 | EP0452040A2 Polysaccharide compounds produced by fermentation |
10/16/1991 | EP0451880A2 An ex vivo tissue perfusion composition and the use thereof |
10/16/1991 | EP0451790A1 3,5-disubstituted 2-isoxazolines and isoxazoles, process for their preparation, medicines containing them and their use |
10/16/1991 | EP0451760A1 Nitrato alkanoic acid derivatives and method for their production |
10/16/1991 | EP0451654A2 Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation |
10/16/1991 | EP0451626A2 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids |
10/16/1991 | EP0451538A2 Use of pyridoindole derivatives in the treatment of ischemic disorders |
10/16/1991 | EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs |
10/16/1991 | EP0191867B1 Tryciclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them |
10/16/1991 | CN1055365A Haloethyl-substituted steroidal enzyme inhibitors |
10/16/1991 | CN1055364A Sulfonylphenyl-beta-d-thioxylosides, their method of preparation and their use in therapeutics |
10/16/1991 | CN1055361A Substituted pyrrole, process for preparing same, preparation containing compounds, and use |
10/16/1991 | CN1055355A Stablizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method therefor and drug stabilized thereby |
10/15/1991 | US5057614 Substituted pyrroles |
10/15/1991 | US5057530 Glycerol derivatives |
10/15/1991 | US5057528 Amino-pyridine compounds useful as anti-arrhythmic agents |
10/15/1991 | US5057496 Dipeptide compounds containing histidine or n-methyl histidine processes for their preparation and compositions containing them |
10/15/1991 | US5057494 Method for preventing tissue damage after an ischemic episode |
10/14/1991 | WO1991016313A1 Substituted benzimidazoles |
10/14/1991 | CA2077897A1 Substituted benzimidazoles |
10/14/1991 | CA2040242A1 Treatment with benzodiazepine compounds |
10/13/1991 | CA2040219A1 3,5-disubstituted 2-isoxazolines and isoxazoles, processes for their preparation, agents containing them and their use |
10/12/1991 | CA2040170A1 Ergoline-8-carboxamides |
10/12/1991 | CA2040062A1 Haemorheological use of n-alkylated 1,4-dihydropyridinedicarboxylic acid esters, and some new compounds |
10/10/1991 | WO1991015486A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors |
10/10/1991 | DE4011285A1 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose Medicines for treating hyperlipidemia and / or atherosclerosis |
10/10/1991 | DE4010536A1 Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure A pharmaceutical aqueous solution of 4- (2- (benzenesulfonylamino) ethyl) -phenoxyacetic acid |
10/10/1991 | CA2039937A1 3-aminochroman derivatives, their preparation process and pharmaceutical compositions containing them |
10/09/1991 | EP0451082A1 Ophthalmic product |
10/09/1991 | EP0451007A1 Sulphonylphenyl-beta-D-thioxylosides, process for their preparation and their use in therapy |
10/09/1991 | EP0450689A1 New isochromane derivatives |
10/09/1991 | EP0450660A1 Anti-atherosclerotic diaryl compound |
10/09/1991 | EP0450588A1 Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates |
10/09/1991 | EP0450566A1 Substituted azoles, method for their preparation, these containing compositions and their use |
10/09/1991 | EP0450559A1 3-hydroxy derivates of mevinic acid |
10/09/1991 | EP0450515A2 Haloethyl-substituted steroidal enzyme inhibitors |
10/09/1991 | EP0450487A1 Benzoxazine derivatives, method for their preparation and their use for treating or prophylaxis of diseases |
10/09/1991 | EP0450429A1 Cyclophanes, process for their preparation and pharmaceuticals containing them |
10/09/1991 | EP0450420A2 Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments |
10/09/1991 | EP0450415A1 Substituted cyanoimino benzopyranes |
10/09/1991 | EP0450232A2 P-Guanidino benzoic acid derivatives for treatment of cerebrovascular contraction |
10/09/1991 | EP0450066A1 Carbostyril derivatives |
10/09/1991 | EP0449943A1 Transdermal and intranasal administration of renin inhibitory peptides |
10/09/1991 | CN1055181A Selective adenosine receptor agents |
10/09/1991 | CN1055172A Di-and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase |
10/08/1991 | US5055613 Metabolites of pentanedioic acid derivatives |